Get the Stockscreener App
2.99
8.28%
-0.27
After Hours:
2.98
-0.01
-0.33%
X 4 Pharmaceuticals Inc stock is traded at $2.99, with a volume of 538.70K.
It is down -8.28% in the last 24 hours and up +4.91% over the past month.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
See More
Previous Close:
$3.26
Open:
$3.14
24h Volume:
538.70K
Relative Volume:
0.14
Market Cap:
$34.11M
Revenue:
$32.77M
Net Income/Loss:
$-101.98M
P/E Ratio:
-0.3111
EPS:
-9.6101
Net Cash Flow:
$-112.43M
1W Performance:
-11.80%
1M Performance:
+4.91%
6M Performance:
-70.69%
1Y Performance:
-85.96%
1-Day Range:
$2.95
$3.17
1-Week Range:
$2.95
$3.49
52-Week Range:
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
Name
X 4 Pharmaceuticals Inc
Sector
Industry
Phone
857-529-8300
Address
61 NORTH BEACON STREET, BOSTON, MA
Compare XFOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
2.99 | 73.18M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-23 | Downgrade | B. Riley Securities | Buy → Neutral |
| Aug-30-23 | Resumed | B. Riley Securities | Buy |
| Dec-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-12-22 | Initiated | Piper Sandler | Overweight |
| Dec-23-19 | Initiated | Oppenheimer | Outperform |
| Dec-18-19 | Initiated | ROTH Capital | Buy |
| Dec-09-19 | Upgrade | Citigroup | Neutral → Buy |
| Dec-05-19 | Initiated | B. Riley FBR | Buy |
| Jun-07-19 | Initiated | Stifel | Buy |
| Jun-05-19 | Initiated | Cowen | Outperform |
View All
X 4 Pharmaceuticals Inc Stock (XFOR) Latest News
What’s the recovery path for long term holders of X4 Pharmaceuticals Inc.GDP Growth & Stepwise Trade Execution Plans - newser.com
How to escape a deep drawdown in X4 Pharmaceuticals Inc.2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Weekly Recap: Can X4 Pharmaceuticals Inc sustain its profitabilityJuly 2025 Rallies & Low Volatility Stock Recommendations - خودرو بانک
Hedge Fund Bets: Will X4 Pharmaceuticals Inc stock go up in YEARJuly 2025 Trends & AI Driven Stock Reports - خودرو بانک
New Highs: What analysts say about X4 Pharmaceuticals Inc stockTrade Volume Report & Risk Managed Investment Signals - خودرو بانک
Price action breakdown for X4 Pharmaceuticals Inc.Short Setup & Low Drawdown Momentum Ideas - newser.com
Detecting support and resistance levels for X4 Pharmaceuticals Inc.Sell Signal & Community Consensus Trade Alerts - newser.com
Understanding X4 Pharmaceuticals Inc.’s price movementJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - newser.com
Is a relief rally coming for X4 Pharmaceuticals Inc. holdersInflation Watch & Low Drawdown Investment Ideas - newser.com
Comparing X4 Pharmaceuticals Inc. in custom built stock radarsJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
How to monitor X4 Pharmaceuticals Inc. with trend dashboards2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com
Chart based exit strategy for X4 Pharmaceuticals Inc.2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
Heatmap analysis for X4 Pharmaceuticals Inc. and competitorsAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Using Ichimoku Cloud for X4 Pharmaceuticals Inc. technicalsJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
What indicators show strength in X4 Pharmaceuticals Inc.Portfolio Risk Report & Smart Swing Trading Alerts - newser.com
Technical analysis overview for X4 Pharmaceuticals Inc. stock2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com
Is X4 Pharmaceuticals Inc. meeting your algorithmic filter criteriaEarnings Beat & AI Enhanced Execution Alerts - newser.com
Chart overlay techniques for tracking X4 Pharmaceuticals Inc.Earnings Performance Report & Weekly Momentum Stock Picks - newser.com
X4 Pharmaceuticals Inc. stock prediction for this weekWeekly Trade Report & Free High Accuracy Swing Entry Alerts - Newser
Is X4 Pharmaceuticals Inc. trending in predictive chart modelsWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
X4 Pharmaceuticals Inc. stock trend forecastQuarterly Market Review & Accurate Buy Signal Notifications - Newser
analyzing x4 pharmaceuticals inc. with risk reward ratio chartsJuly 2025 Fed Impact & Weekly Setup with ROI Potential - Newser
Using R and stats models for X4 Pharmaceuticals Inc. forecastingJuly 2025 Technicals & AI Driven Price Forecasts - Newser
Price momentum metrics for X4 Pharmaceuticals Inc. explainedWeekly Trade Recap & Risk Controlled Swing Trade Alerts - Newser
What technical models suggest about X4 Pharmaceuticals Inc.’s comeback - Newser
Relative strength of X4 Pharmaceuticals Inc. in sector analysis2025 Sector Review & Accurate Entry/Exit Alerts - Newser
Long term hold vs stop loss in X4 Pharmaceuticals Inc.Trade Entry Summary & Low Volatility Stock Suggestions - Newser
Analyzing drawdowns of X4 Pharmaceuticals Inc. with statistical toolsJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
X4 Pharmaceuticals Inc. stock trendline breakdownTrade Analysis Summary & Free High Return Stock Watch Alerts - Newser
How to use a screener to detect X4 Pharmaceuticals Inc. breakouts2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
What the charts say about X4 Pharmaceuticals Inc. todayWeekly Market Outlook & Precise Buy Zone Tips - Newser
Using RSI to spot recovery in X4 Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - Newser
Is X4 Pharmaceuticals Inc. forming a reversal patternRecession Risk & AI Forecast Swing Trade Picks - Newser
Real time scanner hits for X4 Pharmaceuticals Inc. explainedQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Is X4 Pharmaceuticals Inc. showing signs of accumulationMarket Movers & Long-Term Growth Plans - Newser
X 4 Pharmaceuticals Inc Stock (XFOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):